AABB conducts assessments every two years of institutional member facilities that procure, process, store and/or distribute cellular therapy products to ensure they meet the association’s voluntary standards. This section includes lists of
hematopoietic progenitor cell, umbilical cord blood stem cell, somatic cell product and clinical services facilities in the U.S. and worldwide that have earned AABB accreditation.
September 21, 2021
August 17, 2021
July 22, 2021